Calycosin inhibited MIF-mediated inflammatory chemotaxis of macrophages to ameliorate ischemia reperfusion-induced acute kidney injury
Inflammation Research · 2024
DOI: 10.1007/s00011-024-01899-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation Research, 2024. Verfasst von Hong-Lian Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Integrative Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, No. 182, Chunhui Road, …. Hauptthemen laut MEDLINE: Acute Kidney Injury, Chemotaxis, Isoflavones, Macrophage Migration-Inhibitory Factors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: the Basic Research Grant of Luzhou City, National Natural Science Foundation of China, the Innovative Research Fund of College Student.
Abstract (Originalsprache)
BACKGROUND: Inflammatory macrophage infiltration plays a critical role in acute kidney disease induced by ischemia-reperfusion (IRI-AKI). Calycosin is a natural flavone with multiple bioactivities. This study aimed to investigate the therapeutic role of calycosin in IRI-AKI and its underlying mechanism. METHODS: The renoprotective and anti-inflammatory effects of calycosin were analyzed in C57BL/6 mice with IRI-AKI and lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. RNA-seq was used for mechanism investigation. The molecular target of calycosin was screened by in silico methods and validated by surface plasmon resonance (SPR). Macrophage chemotaxis was analyzed using Transwell and agarose gel spot assays. RESULTS: Calycosin treatment significantly reduced serum creatinine and urea nitrogen and attenuated tubular destruction in IRI-AKI mice. Additionally, calycosin markedly suppressed NF-κB signaling activation and the expression of inflammatory mediators IL-1β and TNF-α in IRI-AKI kidneys and LPS-stimulated RAW 264.7 cells. Interestingly, RNA-seq revealed calycosin remarkably downregulated chemotaxis-related pathways in RAW 264.7 cells. Among the differentially expressed genes, Ccl2/MCP-1, a critical chemokine mediating macrophage inflammatory chemotaxis, was downregulated in both LPS-stimulated RAW 264.7 cells and IRI-AKI kidneys. Consistently, calycosin treatment attenuated macrophage infiltration in the IRI-AKI kidneys. Importantly, in silico target prediction, molecular docking, and SPR assay demonstrated that calycosin directly binds to macrophage migration inhibitory factor (MIF). Functionally, calycosin abrogated MIF-stimulated NF-κB signaling activation and Ccl2 expression and MIF-mediated chemotaxis in RAW 264.7 cells. CONCLUSIONS: In summary, calycosin attenuates IRI-AKI by inhibiting MIF-mediated macrophage inflammatory chemotaxis, suggesting it could be a promising therapeutic agent for the treatment of IRI-AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Integrative Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, No. 182, Chunhui Road, District of Longmatan, Luzhou, Sichuan Province, 646000, China.
- Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, 611137, China.
- College of Integrated Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.
- The Department of Urology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.
- The Clinical Trial Research Center, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.
- The Department of Endocrinology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.
Förderung
- the Basic Research Grant of Luzhou City
- National Natural Science Foundation of China
- the Innovative Research Fund of College Student
- The Science and Technology Department of Sichuan Province
- the Luzhou-Southwest Medical University Science and Technology Strategic Cooperation Project
- the Innovation Team Project of Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Zitieren
APA
Wang, H. L., Peng, Z., Li, Y. Q., Wang, Y. X., Li, J. C., Tan, R. Z., Su, H. W., Shen, H. P., Zhao, C. Y., Liu, J., & Wang, L. (2024). Calycosin inhibited MIF-mediated inflammatory chemotaxis of macrophages to ameliorate ischemia reperfusion-induced acute kidney injury. Inflammation Research. https://doi.org/10.1007/s00011-024-01899-0
Vancouver
Wang HL, Peng Z, Li YQ, Wang YX, Li JC, Tan RZ, et al. Calycosin inhibited MIF-mediated inflammatory chemotaxis of macrophages to ameliorate ischemia reperfusion-induced acute kidney injury. Inflammation Research. 2024. doi:10.1007/s00011-024-01899-0
BibTeX
@article{Wang2024,
author = {Wang, Hong-Lian and Peng, Ze and Li, Yu-Qing and Wang, Yi-Xuan and Li, Jian-Chun and Tan, Rui-Zhi and Su, Hong-Wei and Shen, Hong-Ping and Zhao, Chang-Ying and Liu, Jian and Wang, Li},
title = {Calycosin inhibited MIF-mediated inflammatory chemotaxis of macrophages to ameliorate ischemia reperfusion-induced acute kidney injury},
journal = {Inflammation Research},
year = {2024},
doi = {10.1007/s00011-024-01899-0}
}
EUVIMED